This study provides an overview of scientific results on the feasibility of using type III interferons against SARS-CoV-2. We have analyzed data obtained from the PubMed electronic database for the period 2020-2022. The results of our own studies of pharmacological substances based on recombinant IFN-λ1 and its pegylated form are also presented. Completed and ongoing investigations allow us to position IFN-λ as an effective therapeutic agent against SARS-CoV-2.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[potential interferon
4
interferon lambda
4
lambda inhibitor
4
inhibitor sars-cov-2]
4
sars-cov-2] study
4
study overview
4
overview scientific
4
scientific feasibility
4
feasibility type
4
type iii
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!